Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19178 | 518 | 33.2 | 78% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
143 | 3 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 64226 |
230 | 2 | ANTIEPILEPTIC DRUGS//LEVETIRACETAM//EPILEPSY | 20331 |
19178 | 1 | LACOSAMIDE//ESLICARBAZEPINE ACETATE//PERAMPANEL | 518 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LACOSAMIDE | authKW | 5739777 | 29% | 65% | 149 |
2 | ESLICARBAZEPINE ACETATE | authKW | 3050746 | 11% | 89% | 58 |
3 | PERAMPANEL | authKW | 2973171 | 13% | 75% | 67 |
4 | ESLICARBAZEPINE | authKW | 1458075 | 6% | 85% | 29 |
5 | PARTIAL ONSET SEIZURES | authKW | 1164354 | 8% | 49% | 40 |
6 | CARISBAMATE | authKW | 818453 | 4% | 73% | 19 |
7 | BIA 2 093 | authKW | 535884 | 2% | 91% | 10 |
8 | ANTIEPILEPTIC DRUGS | authKW | 446548 | 31% | 5% | 162 |
9 | RWJ 333369 | authKW | 361052 | 1% | 88% | 7 |
10 | EISAI NEUROSCI GEN MED PCU | address | 265261 | 1% | 75% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 11221 | 63% | 0% | 328 |
2 | Pharmacology & Pharmacy | 1378 | 31% | 0% | 162 |
3 | Psychiatry | 639 | 14% | 0% | 70 |
4 | Behavioral Sciences | 578 | 8% | 0% | 41 |
5 | Neurosciences | 165 | 13% | 0% | 66 |
6 | Toxicology | 30 | 3% | 0% | 16 |
7 | Medical Laboratory Technology | 15 | 1% | 0% | 6 |
8 | Chemistry, Analytical | 12 | 4% | 0% | 19 |
9 | Anesthesiology | 10 | 1% | 0% | 6 |
10 | Pediatrics | 9 | 3% | 0% | 13 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EISAI NEUROSCI GEN MED PCU | 265261 | 1% | 75% | 6 |
2 | PHARMACEUT NEUROL SURG | 210524 | 1% | 71% | 5 |
3 | EISAI MED SCI AFFAIRS | 184207 | 1% | 63% | 5 |
4 | EISAI NEUROSCI GEN MED PROD CREAT UNIT | 117895 | 0% | 100% | 2 |
5 | ESTUDOS NEUROL | 117895 | 0% | 100% | 2 |
6 | KLES PRABHAKAR KORE HOSP | 117895 | 0% | 100% | 2 |
7 | EPILEPSY SOC | 86680 | 1% | 29% | 5 |
8 | CLIN SA O CORAZON | 78595 | 0% | 67% | 2 |
9 | ABT LEITER KONSERVAT EPILEPTOL | 58947 | 0% | 100% | 1 |
10 | BIOAVAI IL STUDIES | 58947 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPILEPSIA | 40324 | 15% | 1% | 78 |
2 | EPILEPSY RESEARCH | 33642 | 9% | 1% | 47 |
3 | EPILEPSY & BEHAVIOR | 21979 | 8% | 1% | 39 |
4 | EPILEPSY CURRENTS | 7723 | 1% | 3% | 4 |
5 | SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 6196 | 3% | 1% | 16 |
6 | CNS DRUGS | 4846 | 2% | 1% | 12 |
7 | ACTA NEUROLOGICA SCANDINAVICA | 4266 | 4% | 0% | 21 |
8 | EXPERT REVIEW OF NEUROTHERAPEUTICS | 3694 | 2% | 1% | 8 |
9 | THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS | 3462 | 1% | 2% | 3 |
10 | EPILEPTIC DISORDERS | 2095 | 1% | 1% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LACOSAMIDE | 5739777 | 29% | 65% | 149 | Search LACOSAMIDE | Search LACOSAMIDE |
2 | ESLICARBAZEPINE ACETATE | 3050746 | 11% | 89% | 58 | Search ESLICARBAZEPINE+ACETATE | Search ESLICARBAZEPINE+ACETATE |
3 | PERAMPANEL | 2973171 | 13% | 75% | 67 | Search PERAMPANEL | Search PERAMPANEL |
4 | ESLICARBAZEPINE | 1458075 | 6% | 85% | 29 | Search ESLICARBAZEPINE | Search ESLICARBAZEPINE |
5 | PARTIAL ONSET SEIZURES | 1164354 | 8% | 49% | 40 | Search PARTIAL+ONSET+SEIZURES | Search PARTIAL+ONSET+SEIZURES |
6 | CARISBAMATE | 818453 | 4% | 73% | 19 | Search CARISBAMATE | Search CARISBAMATE |
7 | BIA 2 093 | 535884 | 2% | 91% | 10 | Search BIA+2+093 | Search BIA+2+093 |
8 | ANTIEPILEPTIC DRUGS | 446548 | 31% | 5% | 162 | Search ANTIEPILEPTIC+DRUGS | Search ANTIEPILEPTIC+DRUGS |
9 | RWJ 333369 | 361052 | 1% | 88% | 7 | Search RWJ+333369 | Search RWJ+333369 |
10 | NEW AED | 117895 | 0% | 100% | 2 | Search NEW+AED | Search NEW+AED |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KEATING, GM , (2014) ESLICARBAZEPINE ACETATE: A REVIEW OF ITS USE AS ADJUNCTIVE THERAPY IN REFRACTORY PARTIAL-ONSET SEIZURES.CNS DRUGS. VOL. 28. ISSUE 7. P. 583 -600 | 41 | 84% | 8 |
2 | CAWELLO, W , (2015) CLINICAL PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE OF LACOSAMIDE.CLINICAL PHARMACOKINETICS. VOL. 54. ISSUE 9. P. 901 -914 | 38 | 78% | 4 |
3 | BANACH, M , BOROWICZ, KK , CZUCZWAR, SJ , (2015) PHARMACOKINETIC/PHARMACODYNAMIC EVALUATION OF ESLICARBAZEPINE FOR THE TREATMENT OF EPILEPSY.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 11. ISSUE 4. P. 639 -648 | 39 | 76% | 2 |
4 | TAMBUCCI, R , BASTI, C , MARESCA, M , COPPOLA, G , VERROTTI, A , (2016) UPDATE ON THE ROLE OF ESLICARBAZEPINE ACETATE IN THE TREATMENT OF PARTIAL-ONSET EPILEPSY.NEUROPSYCHIATRIC DISEASE AND TREATMENT. VOL. 12. ISSUE . P. 1251 -1260 | 32 | 80% | 1 |
5 | BRODIE, MJ , (2015) PRACTICAL USE OF NEWER ANTIEPILEPTIC DRUGS AS ADJUNCTIVE THERAPY IN FOCAL EPILEPSY.CNS DRUGS. VOL. 29. ISSUE 11. P. 893 -904 | 44 | 61% | 2 |
6 | FATTORE, C , PERUCCA, E , (2011) NOVEL MEDICATIONS FOR EPILEPSY.DRUGS. VOL. 71. ISSUE 16. P. 2151-2178 | 60 | 47% | 25 |
7 | PATSALOS, PN , BERRY, DJ , (2012) PHARMACOTHERAPY OF THE THIRD-GENERATION AEDS: LACOSAMIDE, RETIGABINE AND ESLICARBAZEPINE ACETATE.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 13. ISSUE 5. P. 699 -715 | 52 | 54% | 14 |
8 | SCOTT, LJ , (2015) LACOSAMIDE: A REVIEW IN FOCAL SEIZURES IN PATIENTS WITH EPILEPSY.DRUGS. VOL. 75. ISSUE 18. P. 2143 -2154 | 34 | 79% | 0 |
9 | HOY, SM , (2013) LACOSAMIDE: A REVIEW OF ITS USE AS ADJUNCTIVE THERAPY IN THE MANAGEMENT OF PARTIAL-ONSET SEIZURES.CNS DRUGS. VOL. 27. ISSUE 12. P. 1125-1142 | 32 | 80% | 6 |
10 | FRAMPTON, JE , (2015) PERAMPANEL: A REVIEW IN DRUG-RESISTANT EPILEPSY.DRUGS. VOL. 75. ISSUE 14. P. 1657 -1668 | 27 | 84% | 4 |
Classes with closest relation at Level 1 |